Verition Fund Management LLC Arbutus Biopharma Corp Transaction History

Verition Fund Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.52 - $3.63 $60,296 - $86,855	23,927 New	23,927 $73,000
Q1 2023 May 15, 2023	BUY	$2.23 - $3.1 $56,577 - $78,650	25,371 New	25,371 $76,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $1,128 - $1,728	600 Added 5.76%	11,011 $21,000
Q2 2022 Aug 15, 2022	BUY	$1.98 - $3.17 $20,613 - $33,002	10,411 New	10,411 $28,000
Q1 2020 May 15, 2020	SELL	$1.01 - $3.42 $176,199 - $596,636	-174,455 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $151,775 - $504,174	174,455 New	174,455 $485,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.